KoreaTimes - Bio

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Business

Bio

Sat, March 25, 2023 | 04:12

Celltrion receives approval to sell anticancer biosimilar Vegzelma in Europe

Celltrion receives approval to sell anticancer biosimilar Vegzelma in Europe

Korean biopharmaceutical firm Celltrion said Friday it has received an approval to sell its anticancer biosimilar Vegzelma in Europe.

2022-08-19 15:52

Samsung Biologics, C&T invest in US biotech firm Senda Biosciences

Samsung Biologics, C&T invest in US biotech firm Senda Biosciences

An investment fund created by Samsung Biologics and Samsung C&T invested $15 million into U.S.-based biotechnology company Senda Biosciences as part of their efforts to foster core technology required to develop next-generation biopharmaceuticals, Samsung Biologics said on Wednesday. Samsung Biologics said the Life Science Fund, jointly formed by itself and Samsung C&T, decid...

Baek Byung-yeul | 2022-08-17 16:16

Yoon promises to foster bio-health industry

Yoon promises to foster bio-health industry

President Yoon Suk-yeol vowed Wednesday to foster the bio-health industry into a key national strategic industry as he met with health experts at a medical research facility.

2022-07-27 14:13

Daesang to set up joint venture with China Sinopharm International

Daesang to set up joint venture with China Sinopharm International

Daesang Life Science, a Korean manufacturer of health functional foods, said Wednesday it has inked a letter of intent with China Sinopharm International to set up a joint venture in a bid to make forays into the Chinese market.

2022-07-27 14:13

Matica Bio aims to join global top 5 cell & gene therapy producers by 2030

Matica Bio aims to join global top 5 cell & gene therapy producers by 2030

Matica Biotechnology, a U.S. subsidiary of CHA Biotech, revealed its goal to join the global top five manufacturers of cell and gene therapy and generate sales of over 1 trillion won ($762.8 million) by 2030, its CEO said Thursday. “The global cell and gene therapy's CDMO (contract development and manufacturing organization) market is expected to grow by more than 20 percent ...

Baek Byung-yeul | 2022-07-21 16:10

Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development

Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development

Korea's state-run National Institute of Infectious Diseases (NIID) said Wednesday it has reached an agreement with Moderna, a U.S. biotech company, to cooperate in the development of a messenger RNA (mRNA) vaccine candidate for severe fever and thrombocytopenia syndrome (SFTS).

2022-07-20 13:18

Split from GSK, Haleon seeks to solidify consumer healthcare leadership

Split from GSK, Haleon seeks to solidify consumer healthcare leadership

Consumer healthcare company Haleon was officially launched on Monday (U.K. time) after completing its spinoff from GSK, its Korean unit said Tuesday. Haleon is a global leading company in the consumer healthcare markets of 170 countries, selling numerous well-known brands such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, Parodontax and Centrum.

Baek Byung-yeul | 2022-07-19 16:34

Moderna says committed to making Omicron-adaptive vaccine candidate available in Aug.

Moderna says committed to making Omicron-adaptive vaccine candidate available in Aug.

Moderna, a U.S. biotech company specializing in messenger RNA (mRNA) coronavirus vaccines, is committed to making its new bivalent vaccine candidate available next month, which reportedly demonstrates a superior antibody response against Omicron variants.

2022-07-19 15:29

SK Biopharm signs deal to commercialize anti-epileptic drug in Latin America

SK Biopharm signs deal to commercialize anti-epileptic drug in Latin America

SK Biopharmaceuticals, a biopharmaceutical affiliate of Korea's SK Group, said Thursday it has signed a deal with Eurofarma Laboratorios SA to develop and commercialize its anti-epileptic drug Cenobamate in 17 Latin American countries.

2022-07-14 14:26

'SK Bioscience's vaccine effective against Omicron variant'

'SK Bioscience's vaccine effective against Omicron variant'

SK Bioscience's SKYCovione coronavirus vaccine was proven to be effective against the Omicron variant. The company said Wednesday that it confirmed the effective immune response when people received a booster shot of the vaccine. SKYCovione, also known as GBP510, is Korea's first COVID-19 vaccine. SK Bioscience obtained approval for the use of the recombinant protein-based va...

Baek Byung-yeul | 2022-07-13 16:05

1 2 3 4 5 6 7 8

Top 10 Stories

1	Zoo shares sad story of what caused Sero the zebra to escape

2	Burnout: Cardiothoracic surgery residents work 102 hours a week

3	More companies adopt electronic voting amid increase in shareholder activism

4	Second daughter of Daesang chairman promoted to vice president

5	North Korea will pay price for reckless provocations, warns Yoon

6	Churches, Seoul gov't unite to fight low birthrate

7	What's next for Do Kwon?

8	FTC criticized for delaying approval for Hanwha's acquisition of DSME

9	Genesis launches 2023 G90 sedan

10	Over 70% of firms unwilling to embrace longer workweek

DARKROOM